Skip to main content
Premium Trial:

Request an Annual Quote

Arnold Levine and Frank Reeves

Premium

Former Rockefeller University president Arnold Levine will leave the university in June, according to Rockefeller sources. On February 11, the university announced that Levine had resigned as president, but would continue his research in cancer biology, in which he used microarrays to study mutations of the p53 gene in cancer.

As a result of Levine’s impending departure, the university’s core microarray facility budget has been scaled back, the sources said.

Luminex of Austin, Texas, has dismissed Frank Reeves, who served as chief financial officer since April 2001. The company will use an interim chief financial officer during the search for a permanent replacement. “There were no financial reporting issues that led to this”, said Mark Chandler, Luminex’s chairman and CEO. “The board just felt that going forward, they wanted to bring in somebody who had more public company experience in the accounting area.”

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.